CFDB - Cystic Fibrosis DataBase

Welcome in CFDB (Cystic Fibrosis DataBase)!

This is a web-based, free access tool for health care professionals, researchers and students to evaluate in real time what are the current evidences about clinical efficacy of interventions in CF.

You'll find more than 1,500 studies divided in 8 sections, including Cochrane reviews, Cochrane protocols, DARE, HTA and Economic reviews, published RCT, published non-RCT, congress abstracts and ongoing trials.

Objective of CFDB (Cystic Fibrosis DataBase)

CFDB is a database and was ideated to classify clinical studies to get answers to specific questions:

  • which interventions are effective, in which groups of CF patients and for which outcomes?
  • to what extent do the results of the literature allow to make decisions for specific clinical issues? What issues need to be studied further?

This tool may help clinicians, researchers, students to have a faster updated view of clinical research in CF by using queries on the main topics in CF care. It could also be helpful to anyone going to design new studies, as it provides a concise description of what is currently known and what issues, on the contrast, need additional research.

Latest articles

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2021
  • Jat Kana R

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2021
  • Thaker V

Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter Randomized Controlled Trial (ACTIVATE-CF).

primary studies published RCT

Details
  • 2021
  • Hebestreit H

Interval versus constant-load exercise training in adults with Cystic Fibrosis.

primary studies published RCT

Details
  • 2021
  • Kaltsakas G

Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.

primary studies published RCT

Details
  • 2021
  • Kelly A

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.

primary studies published RCT

Details
  • 2021
  • Nichols DP

Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.

primary studies published, non RCT

Details
  • 2021
  • Nichols DP